A Kennett Square pharmacy must pay a $1 million civil penalty to resolve a state investigation that found it was producing and packaging thousands of doses of injectable weight loss drugs without undergoing inspections or receiving authorization, officials said Tuesday.

Boothwyn Pharmacy, located at 221 Gale Lane, had its license placed on probation as a result of the state's probe into its compounding of GLP-1 drugs based off popular injectable brand names like Ozempic, Mounjaro and Zepbound. Cheaper, copycat versions of GLP-1s proliferated in recent years after the U.S. Food and Drug Administration temporarily permitted pharmacies to produce them to address shortages of the top brands' active ingredients that help reduce cravings.

The FDA phased out allowing pharmacies to compound GL

See Full Page